Australia markets closed

Cocrystal Pharma, Inc. (8CC.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.4500+0.0500 (+3.57%)
At close: 08:02AM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
26,353
37,144
58,705
33,010
Total cash
26,353
37,144
58,705
33,010
Net receivables
-
-
0
556
Other current assets
1,773
2,243
568
399
Total current assets
29,091
40,178
59,323
34,015
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,925
2,230
2,360
2,208
Accumulated depreciation
-1,803
-1,614
-1,429
-1,119
Net property, plant and equipment
2,122
616
931
1,089
Goodwill
-
0
19,092
19,092
Total non-current assets
2,168
662
20,069
20,227
Total assets
31,259
40,840
79,392
54,242
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,222
614
578
657
Accrued liabilities
1,691
232
615
297
Other current liabilities
-
-
12
61
Total current liabilities
3,262
1,216
1,545
1,358
Non-current liabilities
Total non-current liabilities
1,613
57
298
379
Total liabilities
4,875
1,273
1,843
1,737
Stockholders' equity
Common stock
10
8
8
71
Retained earnings
-315,914
-297,930
-259,093
-244,908
Total stockholders' equity
26,384
39,567
77,549
52,505
Total liabilities and stockholders' equity
31,259
40,840
79,392
54,242